ARTHEx Biotech, a clinical-stage biotechnology company advancing RNA-based therapeutics for neuromuscular disorders, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast ...

Oracle reported a 27% year-on-year increase in net income available to common shareholders for the third quarter of fiscal 2026 (Q3 FY26), with profit rising to $3.7bn from $2.9bn in the same period a ...